Concepedia

Elles Wierenga

EW

Statistics

Publications

4

Citations

219

H-Index

4

Active since

2018

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Oncode Institute

Elles Wierenga is an author at University Medical Center Groningen specializing in medicine, oncology, and tumor biology.

Top concepts

Publications per year

2018–2023

4

Publications

4

Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition‐mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2‐deficient cancer cells

Pepijn M. Schoonen, Yannick P. Kok, Elles Wierenga et al. · Molecular Oncology · 2019 · 82 citations · Full text

, , +17

TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells

Stephanie E. van Gijn, Elles Wierenga, Nathalie van den Tempel et al. · Oncogene · 2018 · 67 citations · Full text

Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51

Anne Margriet Heijink, Colin Stok, David Porubský et al. · Nature Communications · 2022 · 41 citations · Full text

FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics

Colin Stok, Stavroula Tsaridou, Nathalie van den Tempel et al. · Cell Reports · 2023 · 29 citations · Full text

1–4 of 4